Matèries dins de la cerca
Matèries dins de la cerca
- COVID-19 46
- Development
- SARS-CoV-2
- COVID-19 (Disease) 44
- Coronavirus infections 34
- Vaccines 34
- COVID-19 Vaccines 30
- Vaccination 28
- prevention & control 26
- Betacoronavirus 24
- Research 24
- Coronavirus Infections 22
- immunology 20
- Coronaviruses 16
- Drug Development 16
- Treatment 16
- Antiviral agents 14
- Clinical trials 14
- drug effects 14
- drug therapy 14
- virology 14
- Antiviral Agents 12
- Clinical Trials as Topic 12
- Immunological aspects 12
- COVID-19 Pandemic, 2020- 10
- Chemotherapy 10
- Communicable Diseases, Emerging 10
- Mutation 10
- administration & dosage 10
- Genetic Variation 8
-
1
SARS-CoV-2 monoclonal antibody testing in vivo
Publicat 2021Obtenir text complet
Series
Electrònic Audio -
2
SARS-CoV-2 variants implications for immunity and vaccine development /
Publicat 2021Obtenir text complet
Series
Electrònic Audio -
3
SARS-COV-2 human monoclonal antibody therapy update
Publicat 2021Obtenir text complet
Series
Electrònic Audio -
4
The COVID-19 outbreak April 2021 update /
Publicat 2021Obtenir text complet
Series
Electrònic Audio -
5
Genetic surveillance and the emergence of SARS-CoV-2 variants
Publicat 2021Obtenir text complet
Series
Electrònic Audio -
6
SARS-CoV-2 mutations phenotypes and implications for vaccine development /
Publicat 2021Obtenir text complet
Series
Electrònic Audio -
7
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
8
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
9
Imperial College London's saRNA Vaccine - COVAC1
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
10
-
11
Human challenge trials for vaccines against COVID-19
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
12
-
13
-
14
Nanotechnologies in the fight against coronaviruses
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
15
INFbeta therapy for COVID-19 the new SNG001 drug /
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
16
SARS-CoV-2 human monoclonal antibody therapy
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
17
Development of an intranasal vaccine for SARS-CoV-2
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
18
COVID-19 epidemiology and potential treatments follow up interview /
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
19
SARS-COV-2 vaccine current biological targets and considerations /
Publicat 2020Obtenir text complet
Series
Electrònic Audio -
20
The current understanding of the biology of the SARS-COV-2 virus
Publicat 2020Obtenir text complet
Series
Electrònic Audio